Loading chart…
LIVE
CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.
CORONA Remedies Limited (CORONA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The CORONA share price is ₹2,534.20 (+6.49% today), with a price-to-earnings (P/E) ratio of 74.9. MarketRipple tracks the CORONA investment thesis, the ripple-chain impact of market events on CORONA Remedies Limited, and the Healthcare sector outlook.
Open
₹2,479.00
High
₹2,550.00
Low
₹2,478.90
Prev. Close
₹2,379.80
52W High
₹2,584.00
52W Low
₹1,336.60
Day range
₹2,478.90–₹2,550.00
52-week range
₹1,336.60–₹2,584.00
Volume
12K
P/E
74.9
ROE
28.3%
D/E
0.22
Margin
13.3%
CORONA Remedies Limited (NSE: CORONA) is currently trading at ₹2,534.20 (+6.49%).
CORONA Remedies Limited's price-to-earnings (P/E) ratio is 74.9.
CORONA Remedies Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on CORONA Remedies Limited currently reads strongly positive, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.